Advertisement

Topics

PharmaCyte Biotech Releases Shareholder Call Playback Information

09:00 EDT 3 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced t...

Other Sources for this Article

PharmaCyte Biotech, Inc.
Dr. Gerald W. Crabtree, 917.595.2856
Investor Relations Department
Info@PharmaCyte.com

NEXT ARTICLE

More From BioPortfolio on "PharmaCyte Biotech Releases Shareholder Call Playback Information"

Advertisement
Quick Search
Advertisement
Advertisement